Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Onco-ontogeny recapitulates phylogeny – a consideration

Cancers necessarily rely on the (embryologic) fundamental growth patterning genes to serve their uncontrolled growth. Studying a cancer’s behavior, depending on which side of an embryological divide it derives, together with its transcriptome and its relationship to immigrant cells with stem cell potential, intercellular signaling and transducer cascades to transcription factors—all help our understanding of the cancer phenotype. To these can be added the acquired methylome and possibly a “knock-on” metabolome. These aspects are reviewed in the context of Haeckel’s law.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Patient with high grade malignant neuroendocrine tumor of the colon with liver metastases (biopsy proven).

References

  1. Aiello NM, Stanger BZ. Echoes of embryology: using the developmental biology toolkit to study cancer. Dis Model Mech. 2016;9:105–14.

    Article  CAS  Google Scholar 

  2. Kinsler VA. Proteus syndrome and other localised overgrowth disorders. In: Hoeger P, Kinsler V, Yan A, editors. Harper’s textbook of pediatric dermatology. 4th ed. Chichester: J Wiley & Sons Ltd; 2020. p. 1283–95. .

  3. Al-Olabi L, Polubothu S, Dowsett K, Andrews KA, Stadnik P, Joseph AP, et al. Mosaic RAS/Mapk variants cause sporadic vascular malformations which respond to targeted therapy. J Clin Investig. 2018;128:1496–508.

    Article  Google Scholar 

  4. Pinheiro M, Pinto C, Peixoto A, Veiga I, Lopes P, Henrique R, et al. Target gene mutational pattern in Lynch syndrome colorectal carcinomas according to tumour location and germline mutation. Br J Cancer. 2015;113:686–92.

    Article  CAS  Google Scholar 

  5. Xu Y, Pasche B. TGF signalling alterations and susceptibility to colorectal cancer. Hum Mol Genet. 2007;16:R14–20.

    Article  CAS  Google Scholar 

  6. Fromme JE, Schmitz K, Wachter A, Grzelinski M, Zielinski D, Koppel C, et al. FGFR3 mRNA overexpression defines a subset of oligometastatic colorectal cancers with worse prognosis. Oncotarget. 2018;9:32204–18.

    Article  Google Scholar 

  7. Makabe T, Arai E, Hirano T, Ito N, Fukamachi Y, Takahashi Y, et al. Genome-wide DNA methylation profile of early-onset endometrial cancer: its correlation with genetic aberrations and comparison with late-onset endometrial cancer. Carcinogenesis. 2019;40:611–23.

    Article  CAS  Google Scholar 

  8. Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet. 2009;10:295–304.

    Article  CAS  Google Scholar 

  9. Whitehall VLJ, Dumenil TD, McKeone DM, Bond CE, Bettington ML, Buttenshaw RL, et al. Isocitrate dehydrogenase 1 R132C mutation occurs exclusively in microsatellite stable colorectal cancers with the CpG island methylator phenotype. Epigenetics. 2014;9:1454–60.

    Article  CAS  Google Scholar 

  10. Cohen A, Holmen S, Colman H. IDH1 and IDH2 mutations in gliomas. Neurol Neurosci. 2013;13:345–51.

    Google Scholar 

  11. Oberheim-Bush NA, Yu Y, Villanueva-Meyer J, Grimmer M, Hilz S, Solomon D, et al. Temozolomide induced hypermutation associated with high grade transformation, distant recurrence and reduced survival in initially low grade IDH mutant glioma. Proc Am Soc Clin Oncol (Annual Meeting, Chicago). 2020 Abstr. 2506.

  12. Tapial S, Olmedillas-López S, Rueda D, Arriba M, García JL, Vivas A, et al. Cimp-positive status is more representative in multiple colorectal cancers than in unique primary colorectal cancers. Sci Rep. 2019;9:10516.

    Article  Google Scholar 

  13. Sulkowski PL, Sundaram RK, Oeck S, Corso CD, Liu Y, Noorbakhsh S, et al. Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair. Nat Genet. 2018;50:1086–92.

    Article  CAS  Google Scholar 

  14. Ashrafian H, O’Faherty L, Adam J, Steeples V, Chung YL, East P, et al. Expression profiling in progressive stages of fumarate-hydratase deficiency: the contribution of metabolic changes to tumorigenesis. Cancer Res. 2010;70:9153–65.

    Article  CAS  Google Scholar 

  15. Sciacovelli M, Gonçalves E, Johnson TI, Zecchini VR, da Costa AS, Gaude E, et al. Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchyme transition. Nat 2016;537:544-47 Erratum : Nat. 2016;540:150.

    CAS  Google Scholar 

  16. Guinney J, Dienstmann R, Wang X, de Reyniès A, Schlicker A, Soneson C, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21:1350–6.

    Article  CAS  Google Scholar 

  17. Fontana E, Eason K, Cervantes A, Salazar R, Sadanandam A. Context matters-consensus molecular subtypes of colorectal cancer as biomarkers for clinical trials. Ann Oncol. 2019;30:520–27.

    Article  CAS  Google Scholar 

  18. Maffeis V, Nicole L, Cappellesso R. RAS, cellular plasticity and tumor budding in colorectal cancer. Front Oncol. 2019;9:1255–81.

    Article  Google Scholar 

  19. Bae JM, Wen X, Kim TS, Kwak Y, Cho NY, Lee HS, et al. Fibroblast Growth Factor Receptor 1 (FGFR1) amplification detected by droplet digital polymerase chain reaction (ddPCR) is a prognostic factor in colorectal cancers. Cancer Res Treat. 2020;52:74–84.

    Article  CAS  Google Scholar 

  20. Shen MM. Nodal signaling: developmental roles and regulation. Development. 2007;134:1023–34.

    Article  CAS  Google Scholar 

  21. Fessler E, Jansen M, De Sousa E, Melo F, Zhao L, Prasetyanti PR, et al. A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype. Oncogene. 2016;35:6026–37.

    Article  CAS  Google Scholar 

  22. Calon A, Espinet E, Palomo-Ponce S, Tauriello DV, Iglesias M, Céspedes MV, et al. Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. Cancer Cell. 2012;22:571–84.

    Article  CAS  Google Scholar 

  23. Plava J, Cihova M, Burikova M, Matuskova M, Kucerova L, Miklikova S. Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer. Mol Cancer. 2019;18:67.

    Article  Google Scholar 

  24. Jiao X, Nawab O, Patel T, Kossenkov AV, Halama N, Jaeger D, et al. Recent advances targeting CCR5 for cancer and its role in immuno-oncology. Cancer Res. 2019;79:4801–7.

    Article  CAS  Google Scholar 

  25. Mi Z, Bhattacharya SD, Kim VM, Guo H, Talbot LJ, Kuo PC. Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis. Carcinogenesis. 2011;32:477–87.

    Article  CAS  Google Scholar 

  26. Liu J, Wang C, Ma X, Tian Y, Wang C, Fu Y, et al. High expression of CCR5 in melanoma enhances epithelial-mesenchymal transition and metastasis via TGFβ1. J Pathol. 2019;247:481–93.

    Article  CAS  Google Scholar 

  27. Summerbell ER, Mouw JK, Bell JSK, Knippler CM, Pedro B, Arnst JL, et al. Epigenetically heterogeneous tumor cells direct collective invasion through filopodia-driven fibronectin micropatterning. Sci Adv. 2020;6:eaaz6197.

    Article  CAS  Google Scholar 

  28. Padmanaban V, Krol I, Suhail Y, Szczerba BM, Aceto N, Bader JS, et al. E-cadherin is required for metastasis in multiple models of breast cancer. Nature. 2019;573:439–44.

    Article  CAS  Google Scholar 

  29. Gomez DR, Tang C, Zhang J, Blumenschein GR Jr, Hernandez M, Lee JJ, et al. Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, Randomized Study. J Clin Oncol. 2019;37:1558–65.

    Article  CAS  Google Scholar 

  30. Palma DA, Olson R, Harrow S, Gaede S, Louie AV, Haasbeek C, et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet. 2019;393:2051–58.

    Article  Google Scholar 

  31. Nishikawa G, Kawada K, Nakagawa J, Toda K, Ogawa R, Inamoto S, et al. Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression via CCR5. Cell Death Dis. 2019;10:264.

    Article  Google Scholar 

  32. May CL, Kaestner KH. Gut endocrine cell development. Mol Cell Endocrinol. 2010;323:70–5.

    Article  CAS  Google Scholar 

  33. Li HJ, Kapoor A, Giel-Moloney M, Rindi G, Leiter AB. Notch signaling differentially regulates the cell fate of early endocrine precursor cells and their maturing descendants in the mouse pancreas and intestine. Dev Biol. 2012;371:156–69.

    Article  CAS  Google Scholar 

  34. Wallace AS, Anderson RB. Genetic interactions and modifier genes in Hirschsprung’s disease. World J Gastroenterol. 2011;17:4937–44.

    Article  CAS  Google Scholar 

  35. Irving C, Mason I. Signalling by FGF8 from the isthmus patterns anterior hindbrain and establishes the anterior limit of Hox gene expression. Development. 2000;127:177–86.

    CAS  PubMed  Google Scholar 

  36. Theeler BJ, Ellezam B, Melguizo-Gavilanes I, de Groot JF, Mahajan A, Aldape KD, et al. Adult brainstem gliomas: correlation of clinical and molecular features. J Neurol Sci. 2015;353:92–7.

    Article  CAS  Google Scholar 

  37. Perrone-Capano C, Di, Porzio U. Genetic and epigenetic control of midbrain dopaminergic neuron development. Int J Dev Biol. 2000;44:679–87.

    CAS  PubMed  Google Scholar 

  38. Schreck KC, Ranjan S, Skorupan N, Bettegowda C, Eberhart CG, Ames HM, et al. Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas. J Neuro Oncol. 2019;143:87–93.

    Article  CAS  Google Scholar 

  39. Daoud EV, Rajaram V, Cai C, Oberle RJ, Martin GR, Raisanen JM, et al. Adult brainstem gliomas With H3K27M mutation: radiology, pathology, and prognosis. J Neuropath Exp Neur. 2018;77:302–11.

    Article  CAS  Google Scholar 

  40. Plowman PN, Besser GM, Shipley J, Summersgill B, Geddes J, Afshar F. Dramatic response of malignant craniopharyngioma to cis-platin chemotherapy. Should craniopharyngioma be regarded a supra-sellar ‘germ cell’ tumour? Brit J Neurosurg. 2004;18:500–5.

    CAS  Google Scholar 

  41. Turajlic S, Xu H, Litchfield K, Rowan A, Chambers T, Lopez JI, et al. Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal. Cell 2018;173:581–.e12.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr. Bhupinder Sharma for collating the images of our NET patient.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. N. Plowman.

Ethics declarations

Conflict of interest

PNP declares that he has in the past been an advisor to Chronix Biomedical and is currently an advisor to Datar Cancer Genetics.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Plowman, P.N., Plowman, C.E. Onco-ontogeny recapitulates phylogeny – a consideration. Oncogene 40, 1542–1550 (2021). https://doi.org/10.1038/s41388-020-01624-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41388-020-01624-1

Search

Quick links